Compile Data Set for Download or QSAR
Report error Found 21 Enz. Inhib. hit(s) with all data for entry = 12895
TargetNuclear receptor ROR-gamma(Human)
Guangzhou IMD Therapeutics Co.

US Patent
LigandPNGBDBM50524247(CHEMBL4537738 | US12297164, Example 4)
Affinity DataKd:  780nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Guangzhou IMD Therapeutics Co.

US Patent
LigandPNGBDBM50524248(CHEMBL4439690 | US12297164, Example 2)
Affinity DataKd:  380nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Guangzhou IMD Therapeutics Co.

US Patent
LigandPNGBDBM50524231(CHEMBL4558865 | US12297164, Example 1)
Affinity DataKd:  560nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Guangzhou IMD Therapeutics Co.

US Patent
LigandPNGBDBM50524248(CHEMBL4439690 | US12297164, Example 2)
Affinity DataIC50: 30nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Guangzhou IMD Therapeutics Co.

US Patent
LigandPNGBDBM50524231(CHEMBL4558865 | US12297164, Example 1)
Affinity DataIC50: 120nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Guangzhou IMD Therapeutics Co.

US Patent
LigandPNGBDBM50524247(CHEMBL4537738 | US12297164, Example 4)
Affinity DataIC50: 190nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Guangzhou IMD Therapeutics Co.

US Patent
LigandPNGBDBM738193(Positive inhibitor UA | US12297164, Example 9)
Affinity DataIC50: 680nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Guangzhou IMD Therapeutics Co.

US Patent
LigandPNGBDBM50524248(CHEMBL4439690 | US12297164, Example 2)
Affinity DataIC50: 750nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Guangzhou IMD Therapeutics Co.

US Patent
LigandPNGBDBM738179(Compound prepared in Example 6 | US12297164, Examp...)
Affinity DataIC50: 960nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Guangzhou IMD Therapeutics Co.

US Patent
LigandPNGBDBM50524239(CHEMBL4469780 | US12297164, Example 3)
Affinity DataIC50: 1.49E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Guangzhou IMD Therapeutics Co.

US Patent
LigandPNGBDBM26063([3H]T0901317 | US12297164, Example 8)
Affinity DataIC50: 1.70E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent
PDB3D3D Structure (crystal)
TargetNuclear receptor ROR-gamma(Human)
Guangzhou IMD Therapeutics Co.

US Patent
LigandPNGBDBM50524231(CHEMBL4558865 | US12297164, Example 1)
Affinity DataIC50: 2.28E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Guangzhou IMD Therapeutics Co.

US Patent
LigandPNGBDBM26063([3H]T0901317 | US12297164, Example 8)
Affinity DataIC50: 2.50E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent
PDB3D3D Structure (crystal)
TargetNuclear receptor ROR-gamma(Human)
Guangzhou IMD Therapeutics Co.

US Patent
LigandPNGBDBM50524240(CHEMBL4462547 | US12297164, Example 5)
Affinity DataIC50: 2.68E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Guangzhou IMD Therapeutics Co.

US Patent
LigandPNGBDBM50524247(CHEMBL4537738 | US12297164, Example 4)
Affinity DataIC50: 3.46E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Guangzhou IMD Therapeutics Co.

US Patent
LigandPNGBDBM50524240(CHEMBL4462547 | US12297164, Example 5)
Affinity DataIC50: 4.16E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Guangzhou IMD Therapeutics Co.

US Patent
LigandPNGBDBM50524242(CHEMBL4441703 | US12297164, Example 7)
Affinity DataIC50: 4.17E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Guangzhou IMD Therapeutics Co.

US Patent
LigandPNGBDBM50524239(CHEMBL4469780 | US12297164, Example 3)
Affinity DataIC50: 4.85E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Guangzhou IMD Therapeutics Co.

US Patent
LigandPNGBDBM738179(Compound prepared in Example 6 | US12297164, Examp...)
Affinity DataIC50: 5.17E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Guangzhou IMD Therapeutics Co.

US Patent
LigandPNGBDBM738193(Positive inhibitor UA | US12297164, Example 9)
Affinity DataIC50: 9.41E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Guangzhou IMD Therapeutics Co.

US Patent
LigandPNGBDBM50524242(CHEMBL4441703 | US12297164, Example 7)
Affinity DataIC50: 1.02E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/11/2025
Entry Details
Go to US Patent